How can we chop CML with an ASXL1?
Cortes J. Blood, December 2025 – open access publication
This article is a commentary on the article highlighted in September 2025: Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations. Shanmuganathan N. et al Blood 2025